Allergy and Immunology Clinical Studies

Some of the research opportunities available through the Division of Pediatric Allergy and Immunology are listed below. Select a study to review a brief description and requirements. Parents or guardians of children who might be eligible are encouraged to inquire about enrollment. Contact information is listed at the end of each study.

Thank you for exploring these opportunities and helping us to find cures and prevent childhood disease.

Clinical Studies

Researchers

Chronic Granulomatous Disease Progression and Outcomes Review

Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995

Read more

Cow’s Milk Allergy Treatment with Viaskin Milk Patch: The MILES Study – Phase I/II

Trial to Study the Efficacy and Safety of Viaskin Milk for Treating IgE-Mediated Cow’s Milk Allergy in Children

Read more

Peanut Allergy Long-Term Treatment Using Viaskin® Patch: The PEOPLE Study – Phase III

Open-Label Follow-up Study of the PEPITES Study to Evaluate the Long-Term Efficacy and Safety of the Viaskin® Peanut

Read more

Peanut Allergy Long-Term Treatment Using Viaskin® Patch: The REALISE Study – Phase III

Long-Term Assessment of Safety and Therapeutic Benefit of Viaskin® Peanut Epicutaneous Treatment in Peanut-Allergic Children: A 6-Month Randomized, Double-Blind, Placebo-Controlled Phase III Study Followed by an Open Label Active Treatment

Read more

Peanut Allergy Treatment for Toddlers: The EPITOPE Study – Phase III

Trial to Assess the Safety and Efficacy of Viaskin® Peanut in Peanut-allergic Young Children 1-3 Years of Age

Read more

Severe Asthma Treatment with Benralizumab – Phase III

Pharmacokinetics and Pharmacodynamics and Long-term Safety of Benralizumab Administered Subcutaneously in Children with Severe Eosinophilic Asthma

Read more